EMA Authorised: Cinacalcet Accordpharma (cinacalcet hydrochloride) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorised Cinacalcet Accordpharma (cinacalcet hydrochloride) by Accord Healthcare S.L.U. for the treatment of hyperparathyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• Cinacalcet Accordpharma (cinacalcet hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Hyperparathyroidism. MAH: Accord Healthcare S.L.U.. Decision date: 31/03/2026